Skip to content Skip to footer
Nanobiotix’s (NBTX) latest preclinical data suggest that its Nanoprimer technology may do for lipid nanoparticle (LNP) DNA immunotherapy what noise-cancelling headphones did for air travel: make a powerful experience markedly more tolerable. For investors watching the crossroad of oncology and genetic medicines,…
U.S. equities staged a broad-based rebound on Wednesday, April 22, 2026, with major indexes climbing as investors responded to easing geopolitical tensions, resilient earnings, and leadership from large-cap technology. Index and asset snapshot U.S. stocks traded firmly higher through the session, with…